- ProPhase Labs press release (NASDAQ:PRPH): Q1 GAAP EPS of -$0.13.
- Revenue of $1.43M (-39.4% Y/Y).
- The decrease in net revenue was the result of a $1.0 million decrease in consumer products. The Company did not generate any revenues from diagnostic services for the three months ended March 31, 2025 and 2024, respectively.